| Selection of multidrug-resistant bacteria in medicated animal feeds EEF Brown, A Cooper, C Carrillo, B Blais Frontiers in microbiology 10, 456, 2019 | 37 | 2019 |
| Characterization of critical determinants of ACE2–SARS CoV-2 RBD interaction EEF Brown, R Rezaei, TR Jamieson, J Dave, NT Martin, R Singaravelu, ... International Journal of Molecular Sciences 22 (5), 2268, 2021 | 36 | 2021 |
| Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy ME Wedge, VA Jennings, MJF Crupi, J Poutou, T Jamieson, A Pelin, ... Nature communications 13 (1), 1898, 2022 | 28 | 2022 |
| Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry T Azad, R Singaravelu, Z Taha, TR Jamieson, S Boulton, MJF Crupi, ... Molecular Therapy 29 (6), 1984-2000, 2021 | 26 | 2021 |
| SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition T Azad, R Singaravelu, EEF Fekete, Z Taha, R Rezaei, R Arulanandam, ... Biosensors and Bioelectronics 180, 113122, 2021 | 25 | 2021 |
| Implications for SARS-CoV-2 vaccine design: Fusion of spike glycoprotein transmembrane domain to receptor-binding domain induces trimerization T Azad, R Singaravelu, MJF Crupi, T Jamieson, J Dave, EEF Brown, ... Membranes 10 (9), 215, 2020 | 25 | 2020 |
| Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection S Boulton, J Poutou, NT Martin, T Azad, R Singaravelu, MJF Crupi, ... Molecular Therapy 30 (5), 1885-1896, 2022 | 20 | 2022 |
| An economic and robust TMT labeling approach for high throughput proteomic and metaproteomic analysis M Creskey, L Li, Z Ning, EEF Fekete, J Mayne, K Walker, A Ampaw, R Ben, ... Proteomics 23 (21-22), 2200116, 2023 | 10 | 2023 |
| Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen Z Taha, R Arulanandam, G Maznyi, E Godbout, ME Carter-Timofte, ... Molecular Therapy 30 (9), 2998-3016, 2022 | 8 | 2022 |
| Microbiota-directed biotherapeutics: Considerations for quality and functional assessment EE Fekete, D Figeys, X Zhang Gut Microbes 15 (1), 2186671, 2023 | 7 | 2023 |
| CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX JT Whelan, R Singaravelu, F Wang, A Pelin, LA Tamming, G Pugliese, ... Frontiers in Immunology 13, 1050250, 2023 | 3 | 2023 |
| Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment A Surendran, M Jamalkhah, J Poutou, R Birtch, C Lawson, J Dave, ... Frontiers in Immunology 14, 1099459, 2023 | 1 | 2023 |
| Multilevel Proteomic Profiling of Colorectal Adenocarcinoma Caco-2 Cell Differentiation to Characterize an Intestinal Epithelial Model EE Fekete, A Wang, M Creskey, SE Cummings, JR Lavoie, Z Ning, J Li, ... Journal of Proteome Research, 2024 | | 2024 |
| Multilevel proteomic profiling of colorectal adenocarcinoma cell differentiation to characterize an intestinal epithelial model EEF Fekete, A Wang, M Creskey, SE Cummings, JR Lavoie, Z Ning, J Li, ... bioRxiv, 2024.02. 19.581096, 2024 | | 2024 |
| Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry A Wang, EEF Fekete, M Creskey, K Cheng, Z Ning, A Pfeifle, X Li, ... bioRxiv, 2024.03. 13.584844, 2024 | | 2024 |
| Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection CT de Souza, B Austin, Z Taha, J Whelan, ST Khan, A Pelin, R Rezaei, ... Molecular Therapy 30 (2), 2021, 2022 | | 2022 |
Stephen BoultonOttawa Hospital Research Institute在 ohri.ca 的电子邮件经过验证
